Validity evidence of the Health-Related Quality of Life for Drug Abusers Test based on the biaxial model of addiction;Evidencias de validez del test para la evaluación de la calidad de vida en adictos a sustancias psicoactivas a partir del modelo biaxial de la adicción

Psicothema

Volumn 20, Issue 2, 2008, Pages 317-323

  Lozano, Óscar M ^a   Rojas, Antonio J ^b   Pérez, Cristino ^c   González Sáiz, Francisco ^a   Ballesta, Rosario ^a   Izaskun, Bilbao ^a  

^a Drogodependencias e Incorporación Social

^b UNIVERSITY OF ALMERÍA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ADULT; ARTICLE; FEMALE; HEALTH STATUS; HUMAN; MALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION STUDY;

ADULT; FEMALE; HEALTH STATUS; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SUBSTANCE-RELATED DISORDERS;

EID: 42549141181     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Adelekan, M., Green, A., Dasgupta, N., Tallack, F., Stimson, G.V., y Wells, B. (1996). Reliability and validity of the Opiate Treatment Index among a sample opioid users in the United Kingdom. Drug and Alcohol Review, 15, 261-270.
2. American Psychiatric Association (1987/1994). Manual diagnóstico y estadístico de los trastornos mentales. Barcelona: Masson.
3. Badía, X. (2000). La investigación de resultados en salud: de la evidencia a la práctica clínica. Barcelona: Edimac.
4. Chassany, O., Sagnier, P.P., Marquis, P., Fullerton, S., y Aaronson, N.K. (2002). Patient-reported outcomes. The example of health-related quality of life: A European guidance document for the improved integration of health-related quality of life assessment un the drug regulatory process. Drug Information Journal, 36(1), 309-238.
5. Daeppen, J.B., Krieg, M.A., Burnand, B., y Yersin B. (1998). MOSF-SF-36 in evaluating Health-Related Quality of Life in Alcohol-Dependent patients. American Journal of Drug and Alcohol Abuse, 24(4), 685-94.
6. Darke, S., Hall, W., Wodak, A., Heather, N., y Ward J. (1992). Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. British Journal of Addiction, 87, 733-42.
7. Darke, S., Heather, N., Hall, W., Ward, J., y Wodak, A. (1991). Estimating drug consumption in opioid users: Reliability and validity of a recent use episodes method. Brithis Journal of Addiction, 86, 1311-1316.
8. Easton, C., Meza, E., Mager, D., Ulug, B., Kilic, C., Gogus, A., et al. (1997). Test-retest reliability of the alcohol and drug use disorder sections of the schedules for clinical assessment in neuropsychiatry (SCAN). Drug and Alcohol Dependence, 47(3), 187-194.
9. Edwards, G., y Gross, M. (1976). Alcohol dependence: provision description of a clinical syndrome. British Medical Journal, 1, 1058-1061.
10. Embretson S.E., y Reise, S.P. (2000). Item response theory for psychologists. Mahwahn New Jersey: Lawrence Erlbaum Associates.
11. EuroQoL Group (1990). EuroQOL - A new facility for the measurement of health-related quality of life. Health Policy, 16, 199-208.
12. Falck, R., Wang, J., Carlson, R., y Siegal, H. (2000). Crack-cocaine use and health status as defined by the SF-36. Addictive Behaviors, 25(4), 579-584.
13. Gilbody, S.M., House, A.O., y Sheldon, T. (2002). Routine administration of health-related quality of life (HRQoL) and needs assessment instruments to improve psychological outcome - a systematic review. Psychological Medicine, 32, 1345-1356.
14. González-Sáiz, F., Salvador-Canilla, L., Martínez, J.M., López, A., y Ruz, I. (2002). Estudio de validez y fiabilidad de la versión española de la entrevista clínica Opiate Treatment Index (OTI). En I. Castillo y F. González-Sáiz (eds.): Instrumentos para la evaluación en drogodependencias. Madrid: Aula Médica, 133-153.
15. Goldberg, D.P., y Hiller, V.F. (1979). A scaled version of the General Health Questionnaire. Windsor: NFER Publishing Company.
16. Guyatt, G.H., Bombardier, C., y Tugwell, P.X. (1986). Measuring disease-specific quality of life in clinical trials. Canadian Medical Association Journal, 134(8), 889-895.
17. Hunt, S.M., McEwen, J., y McKenna, S.P. (1985). Measuring health stats: A new tool for clinicians and epidemiologists. The Journal of the Royal College of General Practitioners, 35, 185-88.
18. Iraurgi I., Poo M., y Márkez, I. (2004). Valoración del índice de salud SF-36 aplicado a usuarios de programas de metadona. Valores de referencia para la Comunidad Autónoma Vasca. Revista Española de Salud Pública, 78, 609-621.
19. Lord, F.N., y Novick, M.R. (1968). Statistical theories of mental tests scores. Reading, MA: Addison-Wesley.
20. Lozano, O.M., Rojas, A.J., y Pérez, C. (2006). Construcción de un test para medir la calidad de vida relacionada con la salud específico para drogodependientes. Sevilla: Junta de Andalucía.
21. Lozano, O.M., Rojas, A., Pérez, C., Apraiz, B., Sánchez, F., y Marín, A. (2007). Test para la Evaluación de la Calidad de Vida en Adictos a Sustancias Psicoactivas (TECVASP): estudios de fiabilidad y validez. Trastornos Adictivos, 9(2), 99-109.
22. Millson, P., Challacombe, L., Villeneuve, P., Fischer, B., Strike, C.J., Myers et al. (2004). Self-perceived health among Canadian opiate users. Canadian Journal of Public Health, 95(2), 99-103.
23. Moons P., Budts W., y De Geest S. (2006). Critique on the conceptualisation of quality of life: A review and evaluation of different conceptual approaches. International Journal of Nursing Studies, 43, 891-901.
24. Muñoz, J.J., Navas, E., Graña, J.L., y Martínez, R. (2006). Subtipos de drogodependientes en tratamiento: apoyo empírico para una distinción entre tipo A y tipo B. Psicothema, 18(1), 43-51.
25. Ried, L.D., Tueth, M.J., Handberg, E., y Nyanteh, H. (2006). Validating a self-report measure of global subjective well-being to predict adverse clinical outcomes. Quality of Life Research, 15(4), 675-86.
26. Secades, R., y Fernández, J.R. (2001). Tratamientos psicológicos eficaces para la drogadicción: nicotina, alcohol, cocaína y heroína. Psicothema, 13(3), 365-380.
27. The EuroQOL Group (1990). EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199-208.
28. Tsai, S.Y., Chi, L.Y., Lee, CH., y Chou, P. (2007). Health-related quality of life as a predictor of mortality among community-dwelling older person. European Journal of Epidemiology, 22(1), 19-26.
29. Ustun, B., Compton, W., Mager, D., Babor, T., Baiyewu, O., Chatterji, S., et al. (1997). WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: Overview of methods and results. Drug and Alcohol Dependence, 47(3), 161-169.
30. Van der Zanden, B., Dijkgraaf, M., Blanden, P., Boggie, C., Van Ree, J., y Van der Brink, W. (2006). Validity of the EQ-5D as a generis health outcome instrument in a heroin-dependent population. Drug and Alcohol Dependence, 82, 111-8.
31. Ventegodt, S., y Merrick, J. (2003). Psychoactive drugs and quality of life. ScientificWorldJournal, 3, 694-706.
32. Ware, J.E., y Sherbourne, C.D. (1992). The MOS 36-item short-form health survey (SF-36). I conceptual framework and item selection. Medical Care, 30, 473-483.
33. Wing, J.K., Babor, T., Brugha, T., Burke, J., Cooper, J.E., Giel, R. et al. (1990). SCAN: Schules for clinical assessment in neuropsychiatry. Archives General of Psychiatry, 47(6), 589-593.
34. World Health Organisation (1992). International Statistical Classification of Diseases and Related Health Problems (ICD-1O). 1989 Revision. Geneva: World Health Organisation.